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Abstract
Purpose Microsporidiosis is an opportunistic infection that produces chronic diarrhoea and cholangiopathy in patients with 
AIDS, mainly caused by two species of microsporidia, Enterocytozoon bieneusi and Encephalitozon intestinalis. The aim 
of this work was to develop an integral system for the diagnosis of microsporidiosis of the intestine and biliary tract in HIV-
infected patients, comprising microscopic and molecular techniques.
Methods The study population comprised 143 adult patients of both sexes with diagnosis of HIV infection, with chronic 
diarrhoea, and with or without HIV-associated cholangiopathy. Stool studies for microsporidia identification of spores were 
performed on each patient. A video esofagogastroduodenoscopy with biopsy collection was also carried out for routine histol-
ogy and semi-thin sections stained with Azure II. Species identification was carried out by transmission electron microscopy 
and/or polymerase chain reaction for the species E. bieneusi and E. intestinalis.
Results Out of the 143 patients a total of 12.6% (n = 18) were infected with microsporidia. Microsporidia species identified 
in most cases was E. bieneusi (16/18 cases), followed by E. intestinalis (4/18), all of these last ones in coinfection with E. 
bieneusi.
Conclusions Clinical, imaging, microscopic and molecular analyses, when applied in a systematic and integrated approach, 
allow diagnosis and identification of microsporidia at species level in AIDS patients with chronic diarrhoea, and with or 
without HIV-associated cholangiopathy.
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Introduction
Microsporidia are obligate intracellular eukaryotic organ-
isms which lack mitochondria, with non-typical Golgi appa-
ratus and peroxisomes and ribosomes resembling those of 
bacteria [18, 19, 30, 53, 88]. This phylum consists of more 
than 1200 species that infect a wide range of vertebrates 
and invertebrates [16, 109]. To date there are ten genera of 
microsporidia that have been identified as causing human 
infections including Encephalitozoon, Enterocytozoon, 
Trachipleistophora, Pleistophora, Anncalia, Nosema, Vitta-
forma, Tubulinosema, Microsporidium and Endoreticulatus 
[26, 43, 78, 102].
Microsporidia have been recognized as infectious agents 
worldwide, with reported cases in developed and developing 
countries [6, 14, 15, 37, 39, 48, 50, 51, 70, 95]. In Argentina 
the characteristics of the disease are unknown in terms of 
prevalence, morbidity and mortality.
Standard diagnostic methods depend on the detection 
of the organisms in fluids, stool and biopsy specimens by 
light or electron microscopy [104, 105]. Light microscopy 
presents a challenge due to the small size of the organisms 
(about 3 um), with a detection limit of 103–104 spores/
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gram of stool [83]. Meanwhile, electron microscopy is the 
definitive procedure for the identification of species, but 
requires expensive and specialized equipment and has low 
sensitivity. The identification of species of microsporidia 
is clinically useful because of the existence of differences 
in the response to the therapy and depends on the ultras-
tructural and/or molecular analysis. Molecular techniques 
that have been developed for the diagnosis of human 
microsporidiosis correspond to PCR, restriction fragment 
length polymorphism (RFLP), Southern blot analysis, sin-
gle-strand conformational polymorphism (SSCP), in situ 
hybridization, DNA sequencing, real-time PCR, Luminex, 
loop-mediated isothermal amplification (LAMP) and mul-
tiplex commercial kit [20, 21, 29, 32–34, 42, 44, 45, 61, 
62, 67, 69, 71–73, 91, 92, 96, 97, 99, 110].
Enterocytozoon bieneusi and E. intestinalis are the 
most common species infecting the gastrointestinal tract. 
In AIDS patients E. bieneusi has been identified in differ-
ent tissues such as intestinal epithelium, lamina propria, 
bile duct, pancreatic, bronchial and nasal epithelium. E. 
intestinalis has been identified in the intestinal epithelium 
and lamina propria, endothelial, renal tubule cells, biliary 
tract, nasal and bronchial epithelium and other tissues [43, 
104]. Co-infection of more than one species of micro-
sporidia can be found in this group of patients [9]. Patients 
with AIDS and microsporidiosis have a variety of clinical 
manifestations ranging from asymptomatic to severe medi-
cal conditions that depend on the location of the infection 
and CD4 cell count [56–58]. The clinical presentations in 
this group of patients include asymptomatic, symptomatic 
intestinal and symptomatic extraintestinal. Asymptomatic 
clinical forms have a prevalence of about 2–11% [2, 86] 
and are associated with high CD4 cell count. In the intesti-
nal symptomatic forms, patients with a CD4 count greater 
than 200 cells/mm3 present acute or persistent diarrhoea 
[81]. With CD4 counts higher than 200 cells/mm3, acute 
and chronic diarrhoea may evolve towards healing [81]. 
Patients with CD4 counts between 100 and 200 cells/
mm3 present chronic diarrhoea. The CD4 counts lower 
than 100 cells/mm3 are associated with symptoms of diar-
rhoea that can persist for years and lead to extraintestinal 
sites producing cholangiopathy and pancreatitis [43, 105]. 
Watery diarrhoea, dehydration, hypovolemia and death are 
associated with a CD4 count lower than 100 cells/mm3 
[13, 37, 52]. Intestinal perforation has been described in 
a patient infected with E. intestinalis. The infection of the 
biliary tract is one of the most frequent extraintestinal 
clinical manifestations and has been described in 10% of 
patients with AIDS and intestinal microsporidiosis with-
out antiretroviral therapy [59]. The species E. bieneusi 
causes alithiasic cholecystitis, pancreatitis and sclerosing 
cholangitis [80]. The species E. intestinalis causes acalcu-
lous cholecystitis, sclerosing cholangitis, pancreatitis and 
disseminated infection [17, 108]. The level of CD4 cells 
in this group of patients is generally lower than 100 cells/
mm3 [80].
Before the use of antiretroviral therapies, microsporidi-
osis had been reported in at least 15% (and up to 85%) of 
HIV/AIDS patients [89]. Since the advent of antiretroviral 
therapy (ART) and its progressive introduction starting in 
1996, opportunistic infections such as microsporidiosis have 
substantially decreased in developed countries [40] due to 
the reconstitution of the immune system of the patients. This 
contrasts with the situation in developing countries, with 
limited or no access to ART, where opportunistic infections, 
including those due to microsporidia, remain problematic 
[38, 87, 94]. A recent review and meta-analysis [101] 
showed that the global prevalence of microsporidia infection 
in HIV-infected people ranged between 0.7 and 81.3%. The 
estimated pooled prevalence was 11.8% overall, significantly 
higher in low-income countries than in middle-income coun-
tries. The infection rates of the species E. bieneusi in HIV-
infected patients are usually in the range of 1.3–11.6%, with 
higher rates reported in Nigeria, Iran, and Australia [60].
The aim of this work was to develop an integral system 
for the diagnosis of microsporidiosis of the intestine and bil-
iary tract in HIV-infected patients, comprising microscopic 
and molecular techniques in fluid and biopsy specimens.
Materials and Methods
Studied Population and Sample Collection
The studied population comprised 143 adult patients, with 
ages in the range of 20 and 50 years, corresponding to 120 
males and 23 females, diagnosed with HIV who attended 
Hospitals Francisco J. Muñiz and José María Penna, Bue-
nos Aires city, Argentina, complaining of chronic diarrhoea 
(considered when lasting a month or longer) with or without 
HIV-associated cholangiopathy and CD4 counts less than 
500 cells/mm3. Stool samples and duodenal biopsies were 
studied. Samples were collected since 2012 until 2018.
HIV-associated cholangiopathy was confirmed by endo-
scopic retrograde cholangiopancreatography (ERCP) and/or 
magnetic cholangioresonance (CR) of liver and biliary tract. 
A group of 11 patients who met the inclusion criteria were 
selected among the 143 studied patients.
The research protocol was approved by the Ethical Com-
mittee for Research, Hospital Francisco J. Muñiz, protocol 
no. 274.
The stool samples were collected during 7 days in 5% 
formalin saline solution and stored at room temperature until 
processed.
An upper gastrointestinal endoscopy (UGE) was per-
formed to each patient with a Pentax EPM 2000 equipment. 
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Endoscopic images of the duodenal mucosa were classified 
([63], with modifications) as normal duodenum, granular duo-
denum when the mucosa presented congestive base with a thin 
whitish nodularity, jasper duodenum when the folds were flat-
tened with congestive patches, and atrophic duodenum when 
the folds were deleted and visible vessels were seen by trans-
parency. Five or more biopsy specimens from the distal duo-
denum were obtained in all cases showing or not macroscopic 
lesions, and they were stored in 10% formalin, Karnovsky’s 
fixative and at − 20 °C in saline solution. In cases with chol-
angiopathy, peripapillary duodenum samples were obtained.
An ERCP and/or CR were performed in patients with 
clinical manifestations, humoral pattern of cholangiopathy 
and bile duct abnormalities by ultrasonography suggestive 
of cholangiopathy. For the patients who underwent ERCP, a 
papilla biopsy was obtained and fixed in formalin 10% and 
Karnovsky fixative. ERCP was performed with an Olympus 
TJF 100 videoduodenoscope. The bile duct was cannulised 
and ERCP was performed with contrast medium at low pres-
sure. The site, extension and radiological characteristics of 
the lesion were determined. The bile duct abnormalities in 
ERCP and/or CR were classified [22] as papillary stenosis 
(PS), sclerosing cholangitis (SC), association of the two pre-
vious abnormalities and long common bile duct stenosis.
Microscopy Analysis
Faeces samples were concentrated by ethyl ether centrifuga-
tion [93]. Thin smears were prepared from the pellets and 
observed by light microscopy at a magnification of 1000 
after modified trichrome [103] and Gram-chromothrope [68] 
stains.
Formalin-fixed samples were embedded in paraffin and 
sliced in 5–10 μm sections. They were stained with hema-
toxylin and eosin (H&E) and Giemsa for light microscopy 
observation. In cases where compatible structures with 
microsporidia were observed, a methenamine silver staining 
[5] was performed. Samples in Karnovsky’s fixative were 
dehydrated and embedded in polybedaraldita. Semi-thin sec-
tions of 1 μm thickness were sliced and stained with Azure 
II for observation by light microscopy.
The diagnosis of microsporidiosis was carried out by the 
identification of spores and structures of the merogony and 
sporogony stages by light microscopy.
In cases that met diagnostic criteria for microsporidiosis, 
the degree of inflammation and atrophy was determined fol-
lowing the concepts of different authors with modifications 
tailored to our work [36, 84]. We evaluated well-targeted 
5–10 villi where the following characteristics were analysed: 
mucosal appearance, that may have different morpholo-
gies such as a mixed villi pattern (villi have a finger and/
or foliaceus and/or ridges-like appearance), cerebriform, 
convolution, branching or mosaic with flattened mucosa; 
the villus:crypt ratio, considering a normal ratio of 3:1; 
description of epithelial infiltrates, including the number of 
intraepithelial lymphocytes (lower or higher than 30 lym-
phocytes per 100 epithelial cells), the presence or absence 
of polymorphonuclear cells or eosinophils; description of 
infiltrates in the lamina propria, with cell type in the three 
rows below the villi (considering normal 60% plasmocytes 
with a lymphocytes, eosinophils and histiocytes remaining). 
Crypt hyperplasia was considered when an elongation of the 
same size was observed.
In cases where compatible structures with microsporidia 
were detected by light microscopy, the samples were pro-
cessed for TEM as previously described [12] and examined 
using a Carl Zeiss EM-109 equipment.
Molecular Diagnosis
Molecular techniques were carried out in those cases 
with diagnostic criteria of microsporidiosis in stool sam-
ples (spores) and/or biopsy specimens (spores, meronts, 
sporonts).
DNA purification was performed according to previous 
protocols [96], by standard phenol–chloroform extraction 
and ethanol precipitation. For biopsy specimens, an initial 
tripsinization step was added.
A PCR protocol for E. bieneusi was applied as previously 
described [96] for the amplification of a 210-bp fragment 
corresponding to the internal transcribed spacer (ITS) of the 
rRNA genes with the primers set Eb.gc::Eb.gt.
The PCR reaction for E. intestinalis was carried out [31] 
for the amplification of a 520-bp region of the SS rDNA 
employing the primers set SINTF1::SINTR, with modifica-
tions as previously described [98].
Samples resulting negative for E. bieneusi and E. intesti-
nalis were analysed by PCR employing the universal primers 
set 18f::1492r [106] that amplifies most of the small subunit 
rRNA of the microsporidia.
Amplification products were analysed electrophoresis in 
2% agarose gel stained with ethidium bromide.
Results
Prevalence and Pathogenicity
Microorganisms were identified in stool and/or biopsy speci-
mens in 63 cases.
Etiologic agents were: Crytosporidium sp. (n = 22), 
microsporidia (n = 18), Cystoisospora belli (n = 14), Cyto-
megalovirus (n = 12), Giardia duodenalis (n = 7), Stron-
gyloides stercoralis (n = 4), Mycobacterium tuberculosis 
(n = 2), Histoplasma capsulatum (n = 2), Mycobacterium 
avium intracellularis (n = 2), Cryptococus neoformans 
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(n = 1) and Cyclospora cayetanensis (n = 1). Coinfections 
were detected in 12 cases.
The diagnosis of microsporidia was positive in 18 out 
of the 143 cases (12.6%). The species in most cases was E. 
bieneusi (16/18 cases) followed by E. intestinalis (4/18). All 
cases with E. intestinalis were coinfected with E. bieneusi. 
Out of the 18 cases of microsporidiosis, 4 presented cholan-
giopathy and they were identified as E. bieneusi.
Microsporidia-infected patients were aged 23–51 years; 
15 were males and 3 females. Sexual behaviour corre-
sponds to 13 heterosexual and 5 homosexual. Two patients 
were intravenous drug abusers. Diarrhoea duration was 
3–12 months. Most cases had a number of depositions 
higher than 10 per day (12/18), incontinence (11/18), weight 
loss (15/18) and vomiting (10/18). Some patients also pre-
sented dysphagia (2/18), abdominal pain (2/18), right upper 
quadrant abdominal pain (4/18) and pancreatitis (1/18).
In patients not receiving antiretroviral therapy (11/18 
cases) CD4 count was less than 100 cells/mm3 in 8 cases, 
between 100 and 200 cells/mm3 in two cases and in one 
case more than 200/mm3. In patients receiving antiretroviral 
therapy (7/18 cases) CD4 count was less than 100 cells/mm3 
in 1 case, between 100 and 200 cells/mm3 in 5 cases and 
higher than 200 cells/mm3 in only one case. The endoscopic 
appearance of the duodenal mucosa presented a granular 
appearance in 9/18 cases, jasper in 3/18 cases and normal in 
6/18 cases. Table 1 summarizes the most significant clinical 
and microbiological characteristics associated with each of 
the patients with microsporidosis. Evolution of each patient 
is described in Table 2.
Diagnosis by Light Microscopy
Concentrated formalin-preserved faeces were stained with 
modified trichrome and Gram-chromotrope and observed by 
light microscopy (Fig. 1a, b), allowing the identification of 
spores in 13 of 143 cases (9%).
Duodenal biopsy specimens stained with Giemsa, H&E, 
methenamine silver and Azure II allowed the identification 
of structures compatible with microsporidia by light micros-
copy (Figs. 2a–c, 3a, b) in 18 of 143 cases (12.6%). Giemsa, 
H&E and methenamine silver stains identified structures in 
16 of 18 cases and Azure II in all cases.
Degree of Inflammation and Atrophy
In all cases that met diagnostic criteria for microsporidiosis 
the degree of inflammation and atrophy was determined. 
Most patients presented an aspect of the mucosa with a 
mixed villi pattern (17/18) with a villus:crypt ratio of 2:1 
(17/18). In four cases more than 30 lymphocytes per 100 
epithelial cells were found. The lamina propria presented 
infiltrates with mononuclear predominance in most cases 
(15/18). In all patients crypt hyperplasia was observed. 
Among the 10 cases where the identified species was E. 
bieneusi without other microorganisms, in 6 cases there was 
an increased number of intraepithelial lymphocytes.
Diagnosis by Transmission Electron Microscopy
Transmission electron microscopy was performed in four 
patients with microsporidiosis. The species E. bieneusi was 
identified in the 4 cases, one of them in coinfection with E. 
intestinalis (Figs. 2d, 3c).
Molecular Diagnosis
The PCR technique for the identification of the species E. 
bieneusi and E. intestinalis in faecal samples and/or biop-
sies was used in all patients diagnosed with microsporidiosis 
[31, 96]. Faecal samples were analysed in 11/18 cases and 
biopsies in 18/18 cases. The species E. bieneusi was identi-
fied in 16 patients. In 4 of the 16 patients a coinfection with 
the species E. intestinalis was identified (Table 1). In two 
patients with spores in stool and structures compatible with 
microsporidia in duodenal biopsies species E. bieneusi and 
E. intestinalis were not identified, but this sample resulted 
positive employing the universal primers.
Discussion
More than 100 million people are infected with HIV world-
wide. Diarrhoea in patients with HIV may affect 50% of 
cases in the United States and an even higher percentage in 
developing countries, reaching 80% with or without antiret-
roviral therapy [23, 101]. HIV-associated cholangiopathy 
affected 30% of AIDS patients in the pre-ART era [24]. 
However, although fewer cases are described due to antiret-
roviral therapy, they continue appearing [35]. The species 
of microsporidia E. bieneusi and E. intestinalis are cause of 
diarrhoea and HIV-associated cholangiopathy.
With the methodology described here microorganisms 
were identified in 63/143 cases reaching approximately 44%, 
in concordance with previous studies [27, 54]. The most 
common organisms identified in our study were Crypto-
sporidium spp., microsporidia, Cystoisospora belli, Cyto-
megalovirus and Giardia duodenalis. Cryptosporidium 
spp. and microsporidia have been the most common causes 
of chronic diarrhoea in HIV-infected in the pre-ART era 
in numerous series of works [9, 47, 107]. With the use of 
ART opportunistic infections with Cryptosporidium sp. and 
microsporidia decreased their prevalence [28, 55, 66]. Many 
authors agree that diagnosis of microsporidia should be pre-
sent even with the use of ART in patients with chronic diar-

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































mm3 [3, 7, 27]. Our patients correspond mainly to marginal 
population, prisoners, intravenous drug abusers, homeless, 
whose adherence to ART is very low. Due to these character-
istics opportunistic infections continue to be frequent in the 
post ART era and microsporidiosis continues to be a cause 
of morbidity and mortality.
The diagnosis of microsporidia was positive in 18 out 
of the 143 cases representing 12.6%, in concordance with 
previously described prevalence of microsporidia in HIV 
positive patients that varies between 7 and 50% [104]. A 
recent meta-analysis [101] showed that the prevalence of 
microsporidia infection ranged between 0.7 and 81.3% in 
people with HIV with an estimated pooled prevalence of 
11.8% worldwide and 5.6% in Latin America. This last value 
represents only three studies that were done in Venezuela, 
Colombia and Perú [25, 41, 90]. Our present report is the 
first one in Argentina showing the prevalence of intestinal 
microsporidia infection, particularly in HIV-positive patient.
Table 2  Treatment and evolution of patients with microsporidiosis
G Giardia duodenalis, Cr Cryptosporidum spp., Mc microsporidia, Cb Cystoisospora belli, Sarc Sarcocystis sp., Eb Enterocytozoon bieneusi, Ei 
Encephalitozoon intestinalis, ND no data
Case Diarrhoea Adherence 
to HAART 






1 Persisted No No 278 ND G, Cr, Eb Died at day 35
2 Persisted No No 50 ND Eb Died at day 38
3 Persisted No Albendazole 110 ND Eb Died at day 49
4 Persisted No No 100 ND Eb, Ei Died at day 40
5 Persisted No No 50 ND Eb Died at day 34
6 Resolved No Albendazole < 50 ND Eb Died at day 100
7 Persisted No No 50 ND Eb, Ei Died at day 12
8 Resolved Yes Albendazole 179 314 Eb Discharged at day 7
9 Persisted Yes No 194 ND Eb Discharged at day 25
10 Persisted Yes Nitazoxanide 100 ND Eb Discharged at day 25
11 Persisted No Nitazoxanide 50 ND Mc Discharged at day 22
12 Resolved Yes Albendazole, TMS-
SM
178 ND Mc, Cb, Sarc Died at 1 year
13 Persisted Yes Albendazole, clin-
damicin
119 ND Eb, Ei, Cb Discharged at day 37
14 Persisted Yes Albendazole, nita-
zoxanide
316 187 and later 396 Eb, Ei Discharged at day 37
1C Persisted No No 68 ND Cr, Eb Died at day 34
2C Resolved and 
relapsed 4 years 
later
Yes No 7 < 50 Eb Died at 4 years and 
4 months
3C Persisted No No 48 ND Eb Died at day 28
10C Persisted Yes Nitazoxanide 26 ND Eb Died at day 40
Fig. 1  Microsporidia spores in 
faeces observed by light micros-
copy. a Modified trichrome 
stain showing ovoid, pyriform 
or bacillar shaped-spores with 
bright pinkish red stained wall. 
b Gram-chromotrope stain 
showing spores of micro-
sporidia with the presence of 
a vacuole or a diagonal band 




Most patients had chronic diarrhoea evolution of 
3–12 months with an average of 5 months. Some authors 
described a broader range of 1–32 months with a higher 
average of 8 months [4]. The variable number of depositions 
Fig. 2  Enterocytozoon bieneusi in biopsy specimens. a Spores with 
band-shaped or rounded clear structures inside (H&E staining, mag-
nification × 1000). b Multiple intraepithelial spores and stages of 
oval or round shape in direct contact with the cytoplasm of the epi-
thelial cell (Azure II staining, magnification × 1000). c Epithelial cell 
infected with spores leaving the epithelium and reaching the intesti-
nal lumen (Azure II staining, magnification × 1000). d Uninucleated 
spores of E. bieneusi in direct contact with the cytoplasm of host 
cells, in TEM (magnification × 5600)
Fig. 3  Encephalitozoon intestinalis in biopsy specimens. a Spores 
with within displaced parasitophorous vacuoles (Giemsa stain, mag-
nification × 1000). b Merogony and/or sporogony stages surrounded 
by vacuoles (Azure II stain, magnification × 1000). c Spores of E. 




per day was higher than that described in other reports which 
mentioned that most of patients had about five depositions/
day [4, 58]. In our cases the number of depositions was ten 
or more per day. Diarrhoea was accompanied by weight 
loss in almost all patients studied being a similar finding as 
described by numerous authors [3, 4, 7, 27, 58]. A symptom 
that accompanies chronic diarrhoea in most of our patients 
was incontinence, which is not frequently observed [100].
The endoscopic appearance of the duodenal mucosa 
presented a granular appearance in 9/18 cases and jasper 
in 3/18 cases. Changes in the appearance of the duodenal 
mucosa are not specific to an aetiologic agent since we 
observed them with different opportunistic infections (data 
not shown). In 6/18 cases the appearance of the duodenal 
mucosa was normal and biopsies allowed the identification 
of microsporidia. In patients with chronic diarrhoea, low 
CD4 level and normal endoscopic image sampling duodenal 
biopsy can identify aetiologic agents.
According to our results the diagnosis of microsporidi-
osis in patients with chronic diarrhoea should be present 
when it is accompanied by incontinence, weight loss and 
low CD4 cell count, and although VEDA shows a normal 
duodenal mucosa aspect, biopsy specimens’ collection is 
also indicated.
HIV-associated cholangiopathy is characterized by abnor-
malities in the biliary tract in patients with low CD4 level 
[106]. The diagnosis of HIV-associated cholangiopathy was 
achieved in 11/143 of the studied patients reaching about 
8%. With the described methodology, microorganisms were 
identified in 10/11 cases. Other authors identified micro-
organisms only in 60% of cases [80]. The most common 
organisms identified in our patients with HIV-associated 
cholangiopathy were Cryptosporidium spp. and micro-
sporidia. Microsporidia diagnosis was carried out in 4/11 
cases reaching 37%. Other authors identified microsporidia 
in about 10% of patients [1]. The only species identified 
in our series was E. bieneusi. Abdominal pain, diarrhoea, 
weight loss, and CD4 cell count was about 100 cells/mm3 or 
lower occurred in all patients being similar to the description 
in the literature [80]. Abdominal ultrasonography allows to 
identify dilation and wall thickening of the common bile 
duct and other abnormalities in 75% of patients with HIV 
and cholangiopathy [11] and it was useful to identify abnor-
malities in all our cases.
In patients with microsporidiosis and cholangiopathy 
associated with E. bieneusi, the pattern of sclerosing chol-
angitis and papillary stenosis has been described [80]. All 
our patients had sclerosing cholangitis and two of them had 
also papillary stenosis.
Summarizing, the diagnosis of microsporidosis in 
patients with cholangiopathy must be present when vomiting 
and right upper quadrant pain are accompanied by increased 
alkaline phosphatase level, abdominal ultrasonography with 
dilated bile duct and/or thickened walls and CD4 cell count 
less than or equal 100 cells/mm3. It may be accompanied by 
chronic diarrhoea.
Stool samples stained with modified trichrome and Gram-
chromotrope allowed the identification of spores in 13 of 143 
cases constituting about 9% of cases. In similar studies in 
the United States, Brazil, Sweden and Thailand, prevalence 
between 9 and 33% was observed [100, 105]. The use of 
both staining techniques together was very useful since in 
some samples stained with modified trichrome spores resem-
bled bacteria and yeast and Gram-chromotrope technique 
allowed us to differentiate.
Duodenal biopsy samples stained with Giemsa, H&E 
and Azure II helped to identify microsporidia-compatible 
structures by light microscopy in more than 12% of cases. In 
Italy, in a study including 21 patients with AIDS and chronic 
diarrhoea in duodenal biopsies stained with H&E and tolui-
dine blue microsporidia were identified with security in two 
cases (9.52%) and were suspected in 3 cases [10]. In another 
study of 59 patients with AIDS and chronic diarrhoea in 
duodenal biopsies stained with H&E and Giemsa, diagnosis 
of microsporidia was performed in 8 patients reaching 13% 
[79]. However, in a study in Rio de Janeiro in Brazil in 40 
patients with chronic diarrhoea and AIDS which underwent 
duodenal biopsies stained with H&E and Giemsa micro-
sporidia were diagnosed in 11 cases reaching 27.5% [13]. 
Other authors performed the diagnosis of microsporidia in 
duodenal biopsies in patients with diarrhoea in 30% of cases 
[81]. In our study identifying structures compatible with 
microsporidia by light microscopy in 12.6% of cases could 
be real or underestimated. The variable sensitivity of the 
light microscopy in different reports could be given by the 
focal distribution of infected enterocytes and selected sites 
for biopsies that may or may not correspond to infected cells 
[13, 65]. Another possibility is the difficulty in identifying 
structures compatible with microsporidia in cases with low 
parasite burden [10, 65]. Numerous studies agree that the 
identification of intracellular stages compatible with micro-
sporidia depends on careful observation and interpretation of 
histopathology [4, 46, 64]. Some authors suggest re-obser-
vation of histological slides if microsporidian suggestive 
microorganisms are present [4]. This difficulty in identify-
ing compatible parasitic structures with microsporidia using 
H&E and Giemsa was mentioned by different authors [4, 
10, 13, 46, 65, 76]. One reason is that while the spores are 
easier to identify, it is not so with other parasitic stages given 
the minimal contrast between the parasitic structure and the 
cytoplasm of the infected cell [46, 65]. The thickness of the 
slices is another factor because the better definition of the 
structures is obtained with thin slices. Some authors suggest 
that slices of 3 μm in thickness are useful for identifying 
microsporidia in H&E and Giemsa stained samples [65]. 
In our work parasitic stages were identified in 14 duodenal 
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biopsies embedded in polybedaraldita, sliced in semi-thin 
sections of 1 μm and stained with Azure II. The use of semi-
thin sections allowed us to get a better definition of parasitic 
and cellular stages using light microscopy. Our findings in 
semi-thin sections were similar to the recommendations of 
different authors for the identification of microsporidia [46, 
65, 74, 76].
A mixed villi pattern was observed in almost all patients 
(17/18 cases). Villous atrophy and crypt hyperplasia were 
observed in all patients. Other authors have also described 
the villus atrophy and crypt hyperplasia as a frequent find-
ing [11, 58, 74, 77, 82]. However, some microsporidosis 
reported cases presented without villous atrophy [10]. The 
increased intraepithelial lymphocytic infiltrates were found 
in some patients (4/14 cases), similar as described by other 
authors [58, 74, 79, 82]. The infiltrate in lamina propria with 
mononuclear predominance in most cases is a common find-
ing [58].
Although TEM is the best method to identify structures 
and differentiate species, it is time-consuming, expensive, 
with low sensitivity and is not available in all centres pre-
cluding its use as routine [56, 74–76]. In this way, molecu-
lar methods have gained a main role in the identification of 
microsporidia at the species level. The target sequences of 
PCR most commonly used in the diagnosis and identifica-
tion of microsporidia species that infect humans correspond 
to fragments of rRNA genes, with greater emphasis on the 
small subunit and the ITS. The PCR primers were selected 
for an amplification product of less than 1000 bp, improv-
ing diagnosis in formalin-fixed samples [85]. Therefore, we 
employed the primer set Eb.gt::Eb.gc with an amplification 
product of 210 bp to identify the species E. bieneusi and 
the set SINTF1::SINTR with an amplification product of 
520 bp to identify E. intestinalis [31, 96]. The main advan-
tage of using the method of PCR in faecal samples is that 
it is a noninvasive method that allows the differentiation of 
species of microsporidia, which is useful in therapy admin-
istration. The use of PCR in faecal samples allows detection 
of infections with more than one species of microsporidia as 
microscopic observation of spores in faeces does not.
Coinfection of E. bieneusi and E. intestinalis was first 
described in a patient in 1992 [8]. In our work four cases 
coinfected with both species were identified. Other authors 
showed that coinfection with both species is not uncommon 
since they identified it in 9.6% of cases [49].
The interpretation of the clinical manifestations, the use 
of imaging techniques, the application of methods of etio-
logical diagnosis by microscopy in stool and biopsy samples 
and the use of molecular tools applied to different biologi-
cal specimens, enabled, by the systematic and integrated 
employment, the diagnosis and identification of species of 
microsporidia in patients with AIDS, chronic diarrhoea and/
or HIV-associated cholangiopathy.
References
 1. Abdalian R, Heathcote EJ (2006) Sclerosing cholangitis: a focus 
on secondary causes. Hepatology 44:1063–1074
 2. Aissa S, Chabchoub N, Abdelmalek R, Kanoun F, Goubantini A, 
Ammari L, Kilani B, Bouratbine A, Tiouiri-Ben Aissa H, Aoun 
K (2017) Asymptomatic intestinal carriage of microsporidia in 
HIV-positive patients in Tunisia: prevalence, species, and patho-
genesis. Med Sante Trop 27:281–285. https ://doi.org/10.1684/
mst.2017.0697
 3. Anastasi JK, Capili B (2000) HIV and diarrhea in the era of 
HAART: 1998 New York state hospitalizations. Am J Infect 
Control 28:262–266
 4. Asmuth DM, DeGirolami PC, Federman M, Ezratty CR, Pleskow 
DK, Desai G, Wanke CA (1994) Clinical features of microspori-
dosis in patients with AIDS. Clin Infect Dis 18:819–825
 5. Bartholomew JW (1981) Stains for microorganisms in sec-
tions. In: Clark G (ed) Staining procedures, 4th edn. Williams & 
Wilkins, Baltimore, pp 441–473
 6. Bednarska M, Jankowska I, Pawelas A, Piwczyńska K, Bajer 
A, Wolska-Kuśnierz B, Wielopolska M, Welc-Falęciak R 
(2018) Prevalence of Cryptosporidium, Blastocystis, and other 
opportunistic infections in patients with primary and acquired 
immunodeficiency. Parasitol Res 117:2869–2879. https ://doi.
org/10.1007/s0043 6-018-5976-6
 7. Bini EJ, Cohen J (1998) Diagnostic yield and cost-effectiveness 
of endoscopy in chronic human immunodeficiency virus-related 
diarrhea. Gastrointest Endosc 48:354
 8. Blanshard C, Ellis DS, Tovey DG, Dowell S, Gazzard BG (1992) 
Treatment of intestinal microsporidiosis with albendazole in 
patients with AIDS. AIDS 6:311–313
 9. Blanshard C, Francis N, Gazzard BG (1996) Investigation of 
chronic diarrhoea in acquired immunodeficiency syndrome. A 
prospective study of 155 patients. Gut 39:824–832
 10. Boldorini R, Tosoni A, Mazzucco G, Cernuschi M, Caramello 
P, Maran E, Costanzi G, Monga G (1996) Intracellular proto-
zoan infection in small intestinal biopsies of patients with AIDS. 
Pathol Res Pract 192:249–259
 11. Bouche H, Housset C, Dumont JL, Carnot F, Menu Y, Aveline 
B, Belghiti J, Boboc B, Erlinger S, Berthelot P (1993) AIDS-
related cholangitis: diagnostic features and course in 15 patients. 
J Hepatol 17:34–39
 12. Bozzola J, Russel LD (1999) Specimens preparation for transmis-
sion electron microscopy. In: Bozzola J, Russel LD (eds) Elec-
tron microscopy: principles and techniques for biologist, 2nd edn. 
Jones and Bartlett Publishers, Sudbury, pp 16–47
 13. Brasil P, de Lima DB, de Paiva DD, Lobo MS, Sodre FC, da Silva 
SP, Verissimo-Villela E, da Silva EJ, Peralta JM, Morgado M, 
Moura H (1999) Emerging and opportunistic intestinal parasites 
in HIV-infected patients with chronic diarrhea in Rio de Janeiro, 
Brazil. J Eukaryot Microbiol 46:40S–41S
 14. Brasil P, de Lima DB, de Paiva DD, Lobo MS, Sodré FC, Silva 
SP, Villela EV, Silva EJ, Peralta JM, Morgado M, Moura H 
(2000) Clinical and diagnostic aspects of intestinal microsporidi-
osis in HIV-infected patients with chronic diarrhea in Rio de 
Janeiro, Brazil. Rev Inst Med Trop Sao Paulo 42:299–304
 15. Bryan RT, Schwartz DA (1999) Epidemiology of microsporidi-
osis. In: Wittner M, Weiss LM (eds) The microsporidia and 
microsporidiosis. A.M.S. Press, Washington DC, pp 502–516
 16. Cali A, Becnel JJ, Takvorian PM (2017) Microsporidia. In: 
Archibald JM, Simpson AGB, Slamovits CH (eds) Handbook 
of the protists. Publisher Springer International Publishing AG, 
Cham, pp 1559–1618
 17. Cali A, Kotler DP, Orenstein JM (1993) Septata intestinalis 
n.g., n. sp., an intestinal microsporidian associated with chronic 
 Acta Parasitologica
1 3
diarrhea and dissemination in AIDS patients. J Eukaryot Micro-
biol 40:101–112
 18. Canning EU (1993) Microsporidia. In: Kreier JP, Baker JR (eds) 
Parasitic protozoa. Academic Press, New York, pp 299–385
 19. Canning EU, Lom J (1986) The microsporidia of vertebrates. 
Academic, London
 20. Carnevale S, Velásquez JN, Labbé JH, Chertcoff A, Cabrera MG, 
Rodríguez MI (2000) Diagnosis of Enterocytozoon bieneusi by 
PCR in stool samples eluted from filter paper disks. Clin Diagn 
Lab Immunol 7:504–506
 21. Carville A, Mansfield K, Widmer G, Lackner A, Kotler D, Wiest 
P, Gumbo T, Sarbah S, Tzipori S (1997) Development and appli-
cation of genetic probes for detection of Enterocytozoon bieneusi 
in formalin-fixed stools and in intestinal biopsy specimens from 
infected patients. Clin Diagn Lab Immunol 4:405–408
 22. Cello JP (1989) Acquired immunodeficiency syndrome cholan-
giopathy: spectrum of disease. Am J Med 86:539–546
 23. Cello JP, Day LW (2009) Idiopathic AIDS enteropathy and 
treatment of gastrointestinal opportunistic pathogens. Gas-
troenterology 136:1952–1965. https ://doi.org/10.1053/j.gastr 
o.2008.12.073
 24. Cello JP (1997) Hepatobiliary manifestations in AIDS. In: Podol-
sky DK, Friedman LS (eds) Gastroenterology in the centennial 
year and beyond. AGA, Washington DC, pp 399–403
 25. Chacin-Bonilla L, Panunzio AP, Monsalve-Castillo FM, Parra-
Cepeda IE, Martinez R (2006) Microsporidiosis in Venezuela: 
prevalence of intestinal microsporidiosis and its contribution to 
diarrhea in a group of human immunodeficiency virus-infected 
patients from Zulia state. Am J Trop Med Hyg 74:482–486
 26. Choudhary MM, Metcalfe MG, Arrambide K, Bern C, Visves-
vara GS, Pieniazek NJ, Bandea RD, Deleon-Carnes M, Adem 
P, Choudhary MM, Zaki SR, Saeed MU (2011) Tubulinosema 
sp. microsporidian myositis in immunosuppressed patient. 
Emerg Infect Dis 17:1727–1730. https ://doi.org/10.3201/eid17 
09.10192 6
 27. Cohen J, West AB, Bini EJ (2001) Infectious diarrhea in human 
immunodeficiency virus. Gastroenterol Clin N Am 30:637–664
 28. Conteas CN, Berlin OG, Lariviere MJ, Pandhumas SS, Speck 
CE, Porschen R, Nakaya T (1998) Examination of the preva-
lence and seasonal variation of intestinal microsporidiosis in 
the stools of persons with chronic diarrhea and human immu-
nodeficiency virus infection. Am J Trop Med Hyg 58:559–561
 29. Coyle CM, Wittner M, Kotler DP, Noyer C, Orenstein JM, 
Tanowitz HB, Weiss M (1996) Prevalence of microsporidiosis 
due to Enterocytozoon bieneusi and Encephalitozoon (Septata) 
intestinalis among patients with AIDS-related diarrhea: determi-
nation by the polymerase chain reaction to the microsporidian 
small subunit-rRNA gene. Clin Infect Dis 23:1002–1006
 30. Curgy JJ, Vavra J, Vivares C (1980) Presence of ribosomal RNAs 
with prokaryotic properties in microsporidia, eukaryotic organ-
isms. Biol Cell 38:49–51
 31. da Silva AJ, Schwartz DA, Visvesvara GS, de Moura H, Sle-
menda SB, Pieniazek NJ (1997) Detection of Septata intestinalis 
(Microsporidia) Cali et al. 1993 using polymerase chain reaction 
primers targeting the small submit subunit ribosomal RNA cod-
ing region. Mol Diagn 2:47–52
 32. da Silva AJ, Schwartz DA, Visvesvara GS et al (1996) Sensi-
tive PCR diagnosis of infections by Enterocytozoon bieneusi 
(microsporidia) using primers based on the region coding for 
small-subunit rRNA. J Clin Microbiol 34(4):986–987
 33. David F, Schuitema AR, Sarfati C, Liguory O, Hartskeerl RA, 
Derouin F, Molina JM (1996) Detection and species identifica-
tion of intestinal microsporidia by polymerase chain reaction in 
duodenal biopsies from human immunodeficiency virus-infected 
patients. J Infect Dis 174:874–877
 34. del Aguila C, Lopez-Velez R, Fenoy S, Turrientes C, Cobo J, 
Navajas R, Visvesvara GS, Croppo GP, da Silva AJ, Pieniazek 
NJ (1997) Identification of Enterocytozoon bieneusi spores in 
respiratory samples from an AIDS patient with 2-year history of 
intestinal microsporidiosis. J Clin Microbiol 35:1862–1866
 35. Devarbhavi H, Sebastian T, Seetharamu SM, Karanth D (2010) 
HIV/AIDS cholangiopathy: clinical spectrum, cholangiographic 
features and outcome in 30 patients. J Gastroenterol Hepatol 
25:1656–1660. https ://doi.org/10.1111/j.1440-1746.2010.06336 .x
 36. Dickson BC, Streutker CJ, Chetty R (2006) Coeliac disease: an 
update for pathologists. J Clin Pathol 59:1009–1016
 37. Eeftinck Schattenkerk JK, van Gool T, van Ketel RJ, Bartelsman 
JF, Kuiken CL, Terpstra WJ, Reiss P (1991) Clinical significance 
of small-intestinal microsporidiosis in HIV-1-infected individu-
als. Lancet 337:895–898
 38. Espern A, Morio F, Miegeville M, Illa H, Abdoulaye M, Mey-
ssonnier V, Adehossi E, Lejeune A, Cam PD, Besse B, Gay-
Andrieu F (2007) Molecular study of microsporidiosis due to 
Enterocytozoon bieneusi and Encephalitozoon intestinalis among 
human immunodeficiency virus-infected patients from two geo-
graphical areas: Niamey, Niger, and Hanoi, Vietnam. J Clin 
Microbiol 45:2999–3002
 39. Fayer R, Santin-Duran M (2014) Epidemiology of micro-sporidia 
in human infections. In: Weiss L, Becnel JJ (eds) Microsporidia: 
pathogens of opportunity. Wiley, New Yersey, pp 135–164
 40. Fletcher SM, Stark D, Harkness J, Ellis J (2012) Enteric protozoa 
in the developed world: a public health perspective. Clin Micro-
biol Rev 25:420–449. https ://doi.org/10.1128/CMR.05038 -11
 41. Flórez AC, García DA, Moncada L, Beltrán M (2003) Prevalence 
of microsporidia and other intestinal parasites in patients with 
HIV infection, Bogota, 2001. Biomedica 23:274–282
 42. Franzen C, Kuppers R, Müller A et al (1996) Genetic evidence 
for latent Septata intestinalis infection in human immunodefi-
ciency virus-infected patients with intestinal microsporidiosis. 
J Infect Dis 173(4):1038–1040
 43. Franzen C, Müller A (1999) Cryptosporidia and Microsporidia-
waterborne diseases in the immunocompromised host. Diagn 
Microbiol Infect Dis 34:245–262
 44. Franzen C, Müller A, Hartmann P, Kochanek M, Diehl V, Fät-
kenheuer G (1996) Disseminated Encephalitozoon (Sepatata) 
intestinalis infection in a patient with AIDS. N Engl J Med 
335:1610–1611
 45. Franzen C, Müller A, Hegener P, Salzberger B, Hartmann 
P, Fätkenheuer G, Diehl V, Schrappe M (1995) Detection of 
microsporidia (Enterocytozoon bieneusi) in intestinal biopsy 
specimens from human immunodeficiency virus-infected 
patients by PCR. J Clin Microbiol 33:2294–2296
 46. Garcia LS (2002) Laboratory identification of the micro-
sporidia. J Clin Microbiol 40:1892–1901
 47. Gazzard B, Blanshard C (1993) Diarrhoea in AIDS and 
other immunodeficiency states. Baillieres Clin Gastroenterol 
7:387–419
 48. Ghoyounchi R, Mahami-Oskouei M, Rezamand A, Spotin A, 
Aminisani N, Nami S, Pirestani M, Berahmat R, Madadi S 
(2019) Molecular phylodiagnosis of Enterocytozoon bieneusi 
and Encephalitozoon intestinalis in children with cancer: 
microsporidia in malignancies as an emerging opportunistic 
infection. Acta Parasitol. https ://doi.org/10.2478/s1168 6-018-
00012 -w (epub ahead of print)
 49. Graczyk TK, Johansson MA, Tamang L, Visvesvara GS, Moura 
LS, DaSilva AJ, Girouard AS, Matos O (2007) Retrospective 
species identification of microsporidian spores in diarrheic 
fecal samples from human immunodeficiency virus/AIDS 




 50. Greigert V, Pfaff AW, Abou-Bacar A, Candolfi E, Brunet J 
(2018) Intestinal microsporidiosis in Strasbourg from 2014 
to 2016: emergence of an Enterocytozoon bieneusi genotype 
of Asian origin. Emerg Microbes Infect 7:97. https ://doi.
org/10.1038/s4142 6-018-0099-9
 51. Hassan NA, Lim YAL, Mahmud R, Mohd-Shaharuddin N, 
Wan Sulaiman WY, Ngui R (2018) Molecular diagnosis of 
microsporidia among immunocompromised patients in Kuala 
Lumpur, Malaysia. Am J Trop Med Hyg 99:1562–1566. https 
://doi.org/10.4269/ajtmh .17-0901
 52. Hutin YJ, Sombardier MN, Liguory O, Sarfati C, Derouin F, 
Modaï J, Molina JM (1998) Risks factors for intestinal micro-
sporidiosis in patients infected with human immunodeficiency 
virus. J Infect Dis 178:904–907
 53. Ishihara R, Hayashi Y (1968) Some properties of ribosomes 
from the sporoplasm of Nosema bombysis. J Invertebr Pathol 
11:377–385
 54. Kearney DJ, Steuerwald M, Koch J (1999) A prospective study 
of endoscopy in HIV associated diarrhea. Am J Gastroenterol 
94:596–602
 55. Kim LS, Hadley WK, Stansell J, Cello JP, Koch J (1998) 
Declining prevalence of cryptosporidiosis in San Francisco. 
Clin Infect Dis 27:655–656
 56. Kotler DP, Orenstein JM (1995) Microsporidia. In: Blaser MJ, 
Smith PD, Ravdin JI, Greenberg HB, Guerrant RL (eds) Infec-
tions of the gastrointestinal tract. Raven Press, New York, pp 
1129–1140
 57. Kotler DP, Orenstein JM (1997) Clinical syndromes associated 
with microsporidiosis. In: Chandler FW, Schwartz DA, Manz 
HJ, Lack EE (eds) Pathology of infectious diseases. Appleton 
& Lange, Stamford, pp 258–292
 58. Kotler DP, Orenstein JM (1998) Clinical syndromes associated 
with microsporidiosis. Adv Parasitol 40:321–349
 59. Kotler DP, Orenstein JM (1999) Clinical syndromes associated 
with microsporidiosis. In: Wittner M, Weiss LM (eds) The 
microsporidia and microsporidiosis. A.M.S. Press, Washington 
DC, pp 258–292
 60. Li W, Feng Y, Santin M (2019) Host specificity of Enterocyto-
zoon bieneusi and public health implications. Trends Parasitol 
35:436–451. https ://doi.org/10.1016/j.pt.2019.04.004
 61. Liguory O, David F, Sarfati C, Schuitema AR, Hartskeerl RA, 
Derouin F, Modaï J, Molina JM (1997) Diagnosis of infections 
caused by Enterocytozoon bieneusi and Encephalitozoon intes-
tinalis using polymerase chain reaction in stool specimens. 
AIDS 11:723–726
 62. Mansfield KG, Carville A, Shvetz D, MacKey J, Tzipori 
S, Lackner AA (1997) Identification of an Enterocytozoon 
bieneusi-like microsporidian parasite in simian-immunodefi-
ciency-virus-inoculated macaques with hepatobiliary disease. 
Am J Pathol 150:1395–1405
 63. Maratka Z (1984) Terminology, definitions and diagnostic 
criteria in digestive endoscopy. With the collaboration of the 
members of the Terminology Committee of the World Society 
of Digestive Endoscopy/OMED. Scand J Gastroenterol Suppl 
103:1–74
 64. McWilliam LJ, Curry A (1990) Intestinal microsporidiosis in 
AIDS. J Clin Pathol 43:173–174
 65. Michiels JF, Hofman P, Saint Paul MC, Loubière R, Bernard E, 
LeFichoux Y (1993) Pathological features of intestinal micro-
sporidiosis in HIV positive patients: a report of 13 new cases. 
Pathol Res Pract 189:377–383
 66. Mönkemüller KE, Call SA, Lazenby AJ, Wilcox CM (2000) 
Declining prevalence of opportunistic gastrointestinal disease 
in the era of combination antiretroviral therapy. Am J Gastro-
enterol 95:457–462
 67. Morio F, Poirier P, Le Govic Y, Laude A, Valot S, Desoubeaux 
G, Argy N, Nourrisson C, Pomares C, Machouart M, Dalle 
F, Botterel F, Bourgeois N, Cateau E, Leterrier M, Beser J, 
Lavergne RA, Le Pape P (2019) Assessment of the first com-
mercial multiplex PCR kit (ParaGENIE Crypto-Micro Real-
Time PCR) for the detection of Cryptosporidium spp., Entero-
cytozoon bieneusi, and Encephalitozoon intestinalis from fecal 
samples. Diagn Microbiol Infect Dis. https ://doi.org/10.1016/j.
diagm icrob io.2019.04.004
 68. Moura H, Da Silva JL, Sodré FC, Brasil P, Wallmo K, Wahl-
quist S, Wallace S, Croppo GP, Visvesvara GS (1996) Gram-
chromotrope: a new technique that enhaces detection of micro-
sporidial spores in clinical samples. J Eukaryot Microbiol 
43:94S–95S
 69. Nasarudin SN, Zainudin NS, Bernadus M, Nawi AM, Hanafiah 
A, Osman E (2015) Loop-mediated isothermal amplification 
for rapid molecular detection of Enterocytozoon bieneusi in 
faecal specimens. J Med Microbiol 64:1329–1334
 70. Nooshadokht M, Sharifi I, Mohammadi MA, Pirestani M, 
Afgar A, Mahootchi A, Salari S (2017) Intestinal microsporidi-
osis in Iran: infection in immune-compromised and immuno-
competent patients. Curr Med Mycol 3:30–36. https ://doi.
org/10.18869 /acadp ub.cmm.3.1.30
 71. Ombrouck C, Ciceron L, Biligui S, Brown S, Marechal P, van 
Gool T, Datry A, Danis M, Desportes-Livage I (1997) Spe-
cific PCR assay for direct detection of intestinal microsporidia 
Enterocytozoon bieneusi and Encephalitozoon intestinalis in 
fecal specimens from human immunodeficiency virus-infected 
patients. J Clin Microbiol 35:652–655
 72. Ombrouck C, Ciceron L, Desportes-Livage I (1996) Specific 
and rapid detection of Microsporidia in stool specimens from 
AIDS patients by PCR. Parasite 3:85–86
 73. Ombrouck C, Desportes-Livage I, Achbarou A, Gentilini M 
(1996) Specific detection of microsporidia Encephalitozoon 
intestinalis in AIDS patients. C R Acad Sci III 319:39–43
 74. Orenstein JM (1991) Microsporidiosis in the acquired immu-
nodeficiency syndrome. J Parasitol 77:843–864
 75. Orenstein JM (1997) Microsporidiosis. In: Chandler FW, 
Schwartz DA, Manz HJ, Lack EE (eds) Pathology of infectious 
diseases. Appleton & Lange, Stamford, pp 1223–1239
 76. Orenstein JM, Chiang J, Steinberg W, Smith PD, Rotterdam H, 
Kotler DP (1990) Intestinal microsporidiosis as cause of diarrhea 
in human immunodeficiency virus-infected patients: a report of 
20 cases. Hum Pathol 21:475–481
 77. Orenstein JM, Tenner M, Kotler DP (1992) Localization of infec-
tion by microsporidian Enterocytozoon bieneusi in the gastroin-
testinal tract of AIDS patients with diarrhea. AIDS 6:195–197
 78. Pariyakanok L, Satitpitakul V, Putaporntip C, Jongwutiwes S 
(2015) Femtosecond laser-assisted anterior lamellar keratoplasty 
in stromal keratitis caused by an Endoreticulatus-like micro-
sporidia. Cornea 34:588–591. https ://doi.org/10.1097/ICO.00000 
00000 00039 2
 79. Peacock CS, Blanshard C, Tovey DG, Ellis DS, Gazzard BG 
(1991) Histological diagnosis of intestinal microsporidiosis in 
patients with AIDS. J Clin Pathol 44:558–563
 80. Pol S, Romana CA, Richard S, Amouyal P, Desportes-Livage I, 
Carnot F, Pays JF, Berthelot P (1993) Microsporidia infection 
in patients with the human immunodeficiency virus and unex-
plained cholangitis. N Engl J Med 328:95–99
 81. Rabeneck L, Genta RM, Gyorkey F, Clarridge JE, Gyorkey P, 
Foote LW (1995) Observations on the pathological spectrum 
and clinical course of microsporidiosis in men infected with the 
human immunodeficiency virus: follow-up study. Clin Infect Dis 
20:1229–1235
 82. Rijpstra AC, Canning EU, Van Ketel RJ, Eeftinck Schattenkerk 
JK, Laarman JJ (1988) Use of light microscopy to diagnose 
 Acta Parasitologica
1 3
small-intestinal microsporidiosis in patients with AIDS. J Infect 
Dis 157:827–831
 83. Rinder H, Janitschke K, Aspöck H, Da Silva AJ, Deplazes P, 
Fedorko DP, Franzen C, Futh U, Hünger F, Lehmacher A, Meyer 
CG, Molina JM, Sandfort J, Weber R, Löscher T (1998) Blinded, 
externally controlled multicenter evaluation of light microscopy 
and PCR for detection of microsporidia in stool specimens. The 
Diagnostic Multicenter Study Group on Microsporidia. J Clin 
Microbiol 36:1814–1818
 84. Sabrá A, Madi K (1994) Correlação clínica e estudo estereomi-
croscópico e histológico da mucosa intestinal. In: Sabrá A (ed) 
Diarréia Aguda e Crônica em Pediatria. Quarta edição. Editora 
Cultura medica, Rio de Janeiro, pp 82–92
 85. Shibata D (1994) Extraction of DNA from paraffin-embedded 
tissue for analysis by polymerase chain reaction: new tricks from 
an old friend. Hum Pathol 25:561–563
 86. Sodré FC (1996) Microsporidioses humanas: desenvolvimento 
de métodos para o diagnóstico morfológico das microsporidioses 
intestinais em pacientes HIV-positivos no município do Rio de 
Janeiro (Master’s thesis). Instituto Oswaldo Cruz-Fiocruz, Rio 
de Janeiro
 87. Sokolova OI, Demyanov AV, Bowers LC, Didier ES, Yakovlev 
AV, Skarlato SO, Sokolova YY (2011) Emerging microsporid-
ian infections in Russian HIV-infected patients. J Clin Microbiol 
49:2102–2108. https ://doi.org/10.1128/JCM.02624 -10
 88. Sprague V, Becnel JJ, Hazard EI (1992) Taxonomy of the phylum 
microspora. Crit Rev Microbiol Rev 18:285–395
 89. Stentiford GD, Becnel -J, Weiss LM, Keeling PJ, Didier ES, Wil-
liams BP, Bjornson S, Kent ML, Freeman MA, Brown MJF, 
Troemel ER, Roesel K, Sokolova Y, Snowden KF, Solter L 
(2016) Microsporidia—emergent pathogens in the global food 
chain. Trends Parasitol 32:336–348. https ://doi.org/10.1016/j.
pt.2015.12.004
 90. Sulaiman IM, Bern C, Gilman R, Cama V, Kawai V, Vargas D, 
Ticona E, Vivar A, Xiao L (2003) A molecular biologic study of 
Enterocytozoon bieneusi in HIV-infected patients in Lima, Peru. 
J Eukaryot Microbiol 50(Suppl):591–596
 91. Talal AH, Kotler DP, Orenstein JM, Weiss LM (1998) Detection 
of Enterocytozoon bieneusi in fecal specimens by polymerase 
chain reaction analysis with primers to the small-subunit rRNA. 
Clin Infect Dis 26:673–675
 92. Taniuchi M, Verweij JJ, Sethabutr O, Bodhidatta L, Garcia L, 
Maro A, Kumburu H, Gratz J, Kibiki G, Houpt ER (2011) Mul-
tiplex polymerase chain reaction method to detect Cyclospora, 
Cystoisospora, and Microsporidia in stool samples. Diagn Micro-
biol Infect Dis 71:386–390. https ://doi.org/10.1016/j.diagm icrob 
io.2011.08.012
 93. Telemann W (1908) Eine methode zur erleichterung der auffind-
ung von parasiteneiern in den faeces. Dtsch Med Wochenschr 
35:1510–1511
 94. Tumwine JK, Kekitiinwa A, Bakeera-Kitaka S, Ndeezi G, Down-
ing R, Feng X, Akiyoshi DE, Tzipori S (2005) Cryptosporidi-
osis and microsporidiosis in Ugandan children with persistent 
diarrhea with and without concurrent infection with the human 
immunodeficiency virus. Am J Trop Med Hyg 73:921–925
 95. van Gool T, Vetter JC, Weinmayr B, Van Dam A, Derouin F, 
Dankert J (1997) High seroprevalence of Encephalitozoon spe-
cies in immunocompetent subjects. J Infect Dis 175:1020–1024
 96. Velásquez JN, Carnevale S, Guarnera EA, Labbé JH, Chertcoff 
A, Cabrera MG, Rodríguez MI (1996) Detection of the micro-
sporidian parasite Enterocytozoon bieneusi in specimens from 
patients with AIDS by PCR. J Clin Microbiol 34:3230–3232
 97. Velásquez JN, Carnevale S, Oelemann WM, Etchart C, Peralta 
JM (2005) Diagnosis of Enterocytozoon bieneusi by the poly-
merase chain reaction in archival fixed duodenal tissue. Enferm 
Infecc Microbiol Clin 23:218–220
 98. Velásquez JN, Chertcoff AV, Etchart C, di Risio C, Sodré FC, 
Cucher MA, Carnevale S (2012) First case report of infection 
caused by Encephalitozoon intestinalis in a domestic cat and 
a patient with AIDS. Vet Parasitol 190:583–586. https ://doi.
org/10.1016/j.vetpa r.2012.06.034
 99. Verweij JJ, Ten Hove R, Brienen EA, van Lieshout L (2007) 
Multiplex detection of Enterocytozoon bieneusi and Encephalito-
zoon spp. in fecal samples using real-time PCR. Diagn Microbiol 
Infect Dis 57:163–167
 100. Wanachiwanawin D, Manatsathit S, Lertlaituan P, Thakerng-
pol K, Suwanagool P (1998) Intestinal microsporidiosis in HIV 
infected patients with chronic diarrhea in Thailand. Southeast 
Asian J Trop Med Public Health 29:767–771
 101. Wang ZD, Liu Q, Liu HH, Li S, Zhang L, Zhao YK, Zhu XQ 
(2018) Prevalence of Cryptosporidium, microsporidia and Isos-
pora infection in HIV-infected people: a global systematic review 
and meta-analysis. Parasit Vectors 11:28. https ://doi.org/10.1186/
s1307 1-017-2558-x
 102. Watts MR, Chan RC, Cheong EY, Brammah S, Clezy KR, Tong 
C, Marriott D, Webb CE, Chacko B, Tobias V, Outhred AC, 
Field AS, Prowse MV, Bertouch JV, Stark D, Reddel SW (2014) 
Anncaliia algerae microsporidial myositis. Emerg Infect Dis 
20:185–191. https ://doi.org/10.3201/eid20 02.13112 6
 103. Weber R, Bryan RT, Owen RL, Wilcox CM, Gorelkin L, Vis-
vesvara GS (1992) Improved light-microscopical detection of 
microsporidia spores in stool and duodenal aspirates. N Engl J 
Med 326:161–166
 104. Weber R, Bryan RT, Schwartz DA, Owen RL (1994) Human 
microsporidial infections. Clin Microbiol Rev 7:426–461
 105. Weber R, Sauer B, Spycher MA, Deplazes P, Keller R, Ammann 
R, Briner J, Lüthy R (1994) Detection of Septata intestinalis in 
stool specimens and coprodiagnostic monitoring of successful 
treatment with albendazole. Clin Infect Dis 19:342–345
 106. Weiss LM, Vossbrinck CR (1998) Microsporidiosis: molecular 
and diagnostic aspects. Adv Parasitol 40:351–395
 107. Wilcox CM, Rabeneck L, Friedman S (1996) AGA technical 
review: malnutrition and cachexia, chronic diarrhea and hepato-
biliary disease in patients with human immunodeficiency virus 
infection. Gastroenterology 111:1724–1736
 108. Willson R, Harrington R, Stewart B, Fritsche T (1995) Human 
immunodeficiency virus 1- associated necrotizing cholangitis 
caused by infection with Septata intestinalis. Gastroenterology 
108:247–251
 109. Wittner M (1999) Historic perspective on the microsporidia: 
expanding horizons. In: Wittner M, Weiss LM (eds) The micro-
sporidia and microsporidiosis. A.M.S. Press, Washington DC, 
pp 1–6
 110. Zhu X, Wittner M, Tanowitz HB, Kotler D, Cali A, Weiss LM 
(1993) Small subunit rRNA sequence of Enterocytozoon bieneusi 
and its potential diagnostic role with use of the polymerase chain 
reaction. J Infect Dis 168:1570–1575
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
